Search company, investor...
23andMe company logo

23andMe

23andme.com

Founded Year

2006

Stage

Corporate Minority - P2P | IPO

Total Raised

$877.69M

Revenue

$0000 

About 23andMe

23andMe is a personal genetics company dedicated to helping individuals understand genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research.

Headquarters Location

349 Oyster Point Blvd

South San Francisco, California, 94080,

United States

650-938-6300

Compete with 23andMe?

Ensure that your company and products are accurately represented on our platform.

23andMe's Products & Differentiators

    Ancestry +Traits Service

    Traces your genetic heritage and creates your genetic family tree. This product also gives your likelihood of expressing 30+ genetic traits like you fear of heights or if you are more likely to prefer chocolate or vanilla ice cream. You can find details on the product at https://www.23andme.com/

Expert Collections containing 23andMe

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

23andMe is included in 12 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

T

Tech IPO Pipeline

568 items

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

12,628 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,829 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

23andMe Patents

23andMe has filed 118 patents.

The 3 most popular patent topics include:

  • Genetics
  • Molecular biology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/22/2022

4/11/2023

Surnames, Blood tests, Genetics, Human evolution, Hmong

Grant

Application Date

11/22/2022

Grant Date

4/11/2023

Title

Related Topics

Surnames, Blood tests, Genetics, Human evolution, Hmong

Status

Grant

Latest 23andMe News

23andMe connected me with a half-brother I didn’t know about. He made me realize I could pass a rare genetic mutation to my kids.

May 1, 2023

23andMe connected me with a half-brother I didn’t know about. 23andMe connected me with a half-brother I didn’t know about. 13:29, 01 mei 2023 Meghan Thomas did an at-home DNA test because she wanted to track down relatives and find out more about her genetics. Foto: Alice G. Patterson Meghan Thomas did an at-home DNA test because she wanted to track down relatives and find out more about her genetics.Alice G. Patterson Meghan Thomas found out that she was donor conceived on the same day she underwent IVF. She did 23andMe and wound up meeting a half brother who had the same health condition as her. This is Thomas's story, as told to Jane Ridley. This as-told-to essay is based on a conversation with Meghan Thomas. It has been edited for length and clarity. It took me so long to pluck up the courage to do the 23andMe that I'd bought, the at-home DNA kit had nearly expired. I didn't feel emotionally ready until July 2022 — three years after my mom told me I was donor-conceived. She'd kept it secret for 37 years. She said that she hadn't wanted it to affect my memory of my dad, who'd died when I was only five. She also felt shame, she said. I was conceived in 1982, three years after the birth of the world's first IVF baby. It was a new thing back then. Doctors told parents not to tell their kids about it. I got my 23andMe results the same month that I did the test. I pressed the "connect" button. I saw that I had four half-siblings on my father's side.I used the app to connect with one of them, Andrew Robertson, who is three years older than me. We exchanged phone numbers and texted. I mentioned that I was going to be in his home state of Colorado the following January. I shared that I wanted to go skiing towards the end of my trip. "I've never skied out west before," I wrote. "I had major surgery on both of my lungs and need time to acclimatize due to the elevation change," I went on. Meghan Thomas poses in Colorado with her newfound half-brother, Andrew Robertson, and his four-year-old daughter, Alana.Meghan Thomas Andrew said, "Can I call you?" I replied, "Sure." The first thing he said was, "Tell me about your lungs." I told him how one of my lungs collapsed when I was 16 and the other collapsed eight  years later. I'd had staples put in — hopefully to prevent it from happening again. He was quiet for a moment. Then he said, "My lung collapsed when I was 17 and the other collapsed a year later." I gasped. I'd never looked at the medical condition — known as primary spontaneous pneumothorax — as a genetic thing. So I Googled the FLCN gene that you can have tested for the abnormality. Andrew told me that he'd been worried about passing down the condition to his children. His words struck close to home. My husband, Ian Renfrew, and I were trying for a baby via IVF. I  knew that I needed to be tested for the mutation. I've been in poor health since my teens. The doctors were puzzled when the first of my lungs collapsed in 1999. The problem was a lot more common in tall, athletic young men, they said. My back and shoulders were in agony. I could barely breathe since my lung was the size of a grape. Meghan Thomas rides a carousel with her dad, Ken, at the age of three in 1986. He died just two years later.Meghan Thomas The pleurodesis and staple surgery protected my right lung. But my left lung collapsed in 2004 and I had the same procedure. I remember the doctor asking if anyone else in the family had lung issues. I'm pretty sure Mom was in the room, but she didn't say anything about sperm donation. My situation was exacerbated by a series of stomach complications. I had surgery on my bowel in 2005. I manage my symptoms, mostly through diet. However, my fertility doctor has wondered if my problems conceiving could be connected to having scar tissue from the bowel operation. Ian and I decided to try for a baby around 2016. But we were unsuccessful and started IVF. I had my egg retrieval in June 2019. Mom helped pay for the treatment. She knows how she can take care of me in a way that is remarkable. Ian drove me to the clinic and Mom drove me home. I don't hold it against my mom that she didn't tell me I was donor-conceived for so many years I was in the car — still in a fog from the anesthesia — when she said, "Meg, your dad and I also struggled to conceive." She said they'd done IUI. I later discovered that they'd used donor sperm. I'd never had the thought that my dad wasn't my biological dad until that moment. I think part of it came from losing him when I was so young. I did whatever I could to stay connected to him. Little things were always tied to him. My aunt would say jokey things like, "You know you love cheese? You must be a Thomas." I kept my maiden name when I got married in 2010. I don't blame my mom for not telling me for so long that I was donor-conceived. It would have been good to have known the background in terms of my health. But I'm not resentful at all. Unlike now, people didn't talk about fertility treatments when I was growing up. Thomas and her husband, Ian, are trying for a baby via IVF.Alice G. Patterson As for Ian and I, we've had a total of three embryos transferred. None has resulted in pregnancy. Now that I'm 39, we're planning another retrieval. I'm about to be tested for the FLCN gene mutation. It will help me make decisions about our next steps. Hopefully we can expand our family soon. Still, it's gotten bigger already. I'm close to Andrew and have stayed with him and his family in Colorado. Thankfully, he no longer experience discomfort in his lungs. Mine still bother me in connection with my menstrual cycle. It doesn't affect my job as a fertility coach . I'm OK. I just need to be careful about high altitudes and I'm not allowed to scuba dive. Meanwhile, I've connected with two of my other three half-siblings. It's cool how my IVF journey unlocked the secrets of my genetics and my health. Do you have a powerful story to share with Insider? Please send details to [email protected] Read the original article on Insider

23andMe Frequently Asked Questions (FAQ)

  • When was 23andMe founded?

    23andMe was founded in 2006.

  • Where is 23andMe's headquarters?

    23andMe's headquarters is located at 349 Oyster Point Blvd, South San Francisco.

  • What is 23andMe's latest funding round?

    23andMe's latest funding round is Corporate Minority - P2P.

  • How much did 23andMe raise?

    23andMe raised a total of $877.69M.

  • Who are the investors of 23andMe?

    Investors of 23andMe include GSK, Casdin Capital, Fidelity Investments, Altimeter Capital, Foresite Capital and 31 more.

  • Who are 23andMe's competitors?

    Competitors of 23andMe include One Medical, Viome, LifeNome, LetsGetChecked, Sano Genetics, WeGene, CloudSeq, Helix, Eugene, SelfDecode and 24 more.

  • What products does 23andMe offer?

    23andMe's products include Ancestry +Traits Service and 3 more.

Compare 23andMe to Competitors

Color Logo
Color

Color democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

LetsGetChecked Logo
LetsGetChecked

LetsGetChecked offers at-home tests for a variety of conditions. The company builds and delivers at-home testing kits, including hormone tests, fertility tests, HPV tests and wellness tests for cholesterol or diabetes. Its services includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. The company was founded in 2015 and is based in Dublin, Ireland.

Everly Health Logo
Everly Health

Everly Health provides an e-commerce platform that enables customers to buy a variety of test kits online, collect their sample at home, and get informative results without visiting a lab or doctor's office. The platform offers various at-home lab tests including sexual health, thyroid, metabolism, men's health, and breast milk DHA testing, which the company is the exclusive provider of in the U.S. It was formerly known as Everlywell.

Ancestry Logo
Ancestry

Ancestry offers a website offering family history information, historical records and other genealogical information. Ancestry.com offers several localized Web sites designed to empower people to discover, preserve and share family history. Ancestry has more than 2.2 million paying subscribers across its core Ancestry websites and approximately 1.5 million DNA samples in the AncestryDNA database.

Helix Logo
Helix

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.

OmeCare Logo
OmeCare

OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.